Next-generation assessment of human epidermal growth factor receptor 2 (ERBB2) status in breast cancer: A focus on group 4 using the 2018 ASCO/CAP HER2 testing guideline Meeting Abstract
| Authors: | Hoda, R.; Bowman, A.; Zehir, A.; Brogi, E.; Ladanyi, M.; Arcila, M.; Wen, H.; Ross, D. |
| Abstract Title: | Next-generation assessment of human epidermal growth factor receptor 2 (ERBB2) status in breast cancer: A focus on group 4 using the 2018 ASCO/CAP HER2 testing guideline |
| Meeting Title: | 109th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP) |
| Journal Title: | Laboratory Investigation |
| Volume: | 100 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Feb 29-Mar 5 |
| Meeting Location: | Los Angeles, CA |
| ISSN: | 0023-6837 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2020-03-01 |
| Start Page: | 175 |
| End Page: | 177 |
| Language: | English |
| ACCESSION: | WOS:000518328800186 |
| PROVIDER: | wos |
| PUBMED: | 32139858 |
| DOI: | 10.1038/s41374-020-0380-0 |
| Notes: | Meeting Abstract: 185 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work